Literature DB >> 21436082

Modeling human infant MLL leukemia in mice: leukemia from fetal liver differs from that originating in postnatal marrow.

Weili Chen, M Gerard O'Sullivan, Wendy Hudson, John Kersey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21436082      PMCID： PMC3069683          DOI： 10.1182/blood-2010-11-317529

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  6 in total

1.  Immunobiological diversity in infant acute lymphoblastic leukemia is related to the occurrence and type of MLL gene rearrangement.

Authors:  M W J C Jansen; L Corral; V H J van der Velden; R Panzer-Grümayer; M Schrappe; A Schrauder; R Marschalek; C Meyer; M L den Boer; W J C Hop; M G Valsecchi; G Basso; A Biondi; R Pieters; J J M van Dongen
Journal:  Leukemia       Date:  2007-02-01       Impact factor: 11.528

2.  In utero origins of childhood leukaemia.

Authors:  Mel Greaves
Journal:  Early Hum Dev       Date:  2004-11-19       Impact factor: 2.079

3.  Malignant transformation initiated by Mll-AF9: gene dosage and critical target cells.

Authors:  Weili Chen; Ashish R Kumar; Wendy A Hudson; Quanzhi Li; Baolin Wu; Rodney A Staggs; Erik A Lund; Thien N Sam; John H Kersey
Journal:  Cancer Cell       Date:  2008-05       Impact factor: 31.743

4.  Prenatal and postnatal myeloid cells demonstrate stepwise progression in the pathogenesis of MLL fusion gene leukemia.

Authors:  Jennifer J Johnson; Weili Chen; Wendy Hudson; Qing Yao; Marnie Taylor; Terence H Rabbitts; John H Kersey
Journal:  Blood       Date:  2002-12-19       Impact factor: 22.113

5.  An Mll-AF9 fusion gene made by homologous recombination causes acute leukemia in chimeric mice: a method to create fusion oncogenes.

Authors:  J Corral; I Lavenir; H Impey; A J Warren; A Forster; T A Larson; S Bell; A N McKenzie; G King; T H Rabbitts
Journal:  Cell       Date:  1996-06-14       Impact factor: 41.582

6.  Gene expression profiling-based dissection of MLL translocated and MLL germline acute lymphoblastic leukemia in infants.

Authors:  Ronald W Stam; Pauline Schneider; Jill A P Hagelstein; Marieke H van der Linden; Dominique J P M Stumpel; Renee X de Menezes; Paola de Lorenzo; Maria G Valsecchi; Rob Pieters
Journal:  Blood       Date:  2009-12-23       Impact factor: 22.113
  6 in total
  15 in total

1.  MLL leukemia induction by genome editing of human CD34+ hematopoietic cells.

Authors:  Corina Buechele; Erin H Breese; Dominik Schneidawind; Chiou-Hong Lin; Johan Jeong; Jesus Duque-Afonso; Stephen H K Wong; Kevin S Smith; Robert S Negrin; Matthew Porteus; Michael L Cleary
Journal:  Blood       Date:  2015-08-26       Impact factor: 22.113

2.  MLL leukemia induction by t(9;11) chromosomal translocation in human hematopoietic stem cells using genome editing.

Authors:  Corina Schneidawind; Johan Jeong; Dominik Schneidawind; In-Suk Kim; Jesús Duque-Afonso; Stephen Hon Kit Wong; Masayuki Iwasaki; Erin H Breese; James L Zehnder; Matthew Porteus; Michael L Cleary
Journal:  Blood Adv       Date:  2018-04-24

3.  Context matters in MLL-AF9-driven leukemias.

Authors:  Christopher Y Park
Journal:  Blood       Date:  2016-05-12       Impact factor: 22.113

4.  The mitochondrial pathway and reactive oxygen species are critical contributors to interferon-α/β-mediated apoptosis in Ubp43-deficient hematopoietic cells.

Authors:  Hwa Young Yim; Young Yang; Jong-Seok Lim; Myeong Seok Lee; Dong-Er Zhang; Keun Il Kim
Journal:  Biochem Biophys Res Commun       Date:  2012-06-05       Impact factor: 3.575

Review 5.  Mouse models of MLL leukemia: recapitulating the human disease.

Authors:  Thomas A Milne
Journal:  Blood       Date:  2017-02-08       Impact factor: 22.113

6.  Differential role of Id1 in MLL-AF9-driven leukemia based on cell of origin.

Authors:  Na Man; Xiao-Jian Sun; Yurong Tan; Marta García-Cao; Fan Liu; Guoyan Cheng; Megan Hatlen; Haiming Xu; Ronit Shah; Nolan Chastain; Na Liu; Gang Huang; Yuan Zhou; Mengyao Sheng; Junhong Song; Feng-Chun Yang; Robert Benezra; Stephen D Nimer; Lan Wang
Journal:  Blood       Date:  2016-03-04       Impact factor: 22.113

7.  Inhibition of DOT1L and PRMT5 promote synergistic anti-tumor activity in a human MLL leukemia model induced by CRISPR/Cas9.

Authors:  Kathy-Ann Secker; Hildegard Keppeler; Silke Duerr-Stoerzer; Hannes Schmid; Dominik Schneidawind; Thomas Hentrich; Julia M Schulze-Hentrich; Barbara Mankel; Falko Fend; Corina Schneidawind
Journal:  Oncogene       Date:  2019-08-15       Impact factor: 9.867

8.  Use of Genome Engineering to Create Patient Specific MLL Translocations in Primary Human Hematopoietic Stem and Progenitor Cells.

Authors:  Erin H Breese; Corina Buechele; Catherine Dawson; Michael L Cleary; Matthew H Porteus
Journal:  PLoS One       Date:  2015-09-09       Impact factor: 3.240

9.  Modeling Human Leukemia Immunotherapy in Humanized Mice.

Authors:  Jinxing Xia; Zheng Hu; Satoshi Yoshihara; Yuying Li; Chun-Hui Jin; Shulian Tan; Wei Li; Qingfeng Chen; Megan Sykes; Yong-Guang Yang
Journal:  EBioMedicine       Date:  2016-06-23       Impact factor: 8.143

Review 10.  Genetically engineered mouse models of human B-cell precursor leukemias.

Authors:  Julia Hauer; Arndt Borkhardt; Isidro Sánchez-García; César Cobaleda
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.